← Research library

Pharmaceutical grade synthetic peptide Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu ameliorates DSS-induced murine colitis by reducing the number and pro-inflammatory activity of colon tissue-infiltrating Ly6G+ granulocytes and Ly6C+ monocytes.

Animal research · 2020

What was studied
Mice with dextran-sodium-sulphate-induced colitis
Main finding
Gepon reduced experimental colitis manifestations, inflammatory-cell infiltration and selected inflammatory gene signals.

Study data at a glance

Participants or experimental model
Mice with dextran-sodium-sulphate-induced colitis
Reported results
Gepon reduced experimental colitis manifestations, inflammatory-cell infiltration and selected inflammatory gene signals.
Study limitations and source details

Study limitations

  • A chemically induced mouse model does not establish benefit or safety in human ulcerative colitis.
  • Full methods, reporting completeness and independent replication remain to be appraised.

Source details

Original journal report

Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.

Abstract reviewed

Sources checked

Citation

Animal / experimentalEnglish abstract

Chulkina MM, Pichugin AV, Ataullakhanov RI. Pharmaceutical grade synthetic peptide Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu ameliorates DSS-induced murine colitis by reducing the number and pro-inflammatory activity of colon tissue-infiltrating Ly6G+ granulocytes and Ly6C+ monocytes. Peptides · PMID 32621844

Study source ↗ · DOI 10.1016/j.peptides.2020.170364 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards